Publicación: Ib-M6 antimicrobial peptide: Antibacterial activity against clinical isolates of Escherichia coli and molecular docking
Ib-M6 antimicrobial peptide: Antibacterial activity against clinical isolates of Escherichia coli and molecular docking
dc.contributor.author | Flórez Castillo, Johanna-Marcela | |
dc.contributor.author | Rondón Villarreal, Paola | |
dc.contributor.author | Ropero Vega, José Luis | |
dc.contributor.author | Mendoza Espinel, Stephany Y. | |
dc.contributor.author | Moreno Amézquita, July A. | |
dc.contributor.author | Méndez Jaimes, Karen D. | |
dc.contributor.author | Farfán García, Ana Elvira | |
dc.contributor.author | Gómez Rangel, Sergio-Yebrail | |
dc.contributor.author | Gómez Duarte, Oscar Gilberto | |
dc.contributor.researchgroup | CLINIUDES | spa |
dc.contributor.researchgroup | CIBAS | spa |
dc.date.accessioned | 2021-10-06T15:11:38Z | |
dc.date.available | 2021-10-06T15:11:38Z | |
dc.date.issued | 2020-03-12 | |
dc.description | Digital | spa |
dc.description.abstract | The Ib-M6 peptide has antibacterial activity against non-pathogenic Escherichia coli K-12 strain. The first part of this study determines the antibacterial activity of Ib-M6 against fourteen pathogenic strains of E. coli O157:H7. Susceptibility assay showed that Ib-M6 had values of Minimum Inhibitory Concentration (MIC) lower than streptomycin, used as a reference antibiotic. Moreover, to predict the possible interaction between Ib-M6 and outer membrane components of E. coli, we used molecular docking simulations where FhuA protein and its complex with Lipopolysaccharide (LPS–FhuA) were used as targets of the peptide. FhuA/Ib-M6 complexes had energy values between −39.5 and −40.5 Rosetta Energy Units (REU) and only one hydrogen bond. In contrast, complexes between LPS–FhuA and Ib-M6 displayed energy values between −25.6 and −40.6 REU, and the presence of five possible hydrogen bonds. Hence, the antimicrobial activity of Ib-M6 peptide shown in the experimental assays could be caused by its interaction with the outer membrane of E. coli. View Full-Text | spa |
dc.description.researcharea | Ciencias básicas biomédicas, epidemiología, salud pública enfermedades infecciosas, enfermedades no transmisibles epidemiología, salud y desarrollo, discapacidad | spa |
dc.description.researcharea | Ciencias Básicas y Aplicadas para la Sostenibilidad | spa |
dc.format.extent | 1 p. | spa |
dc.format.mimetype | application/pdf | spa |
dc.identifier.doi | 10.3390/antibiotics9020079 | |
dc.identifier.uri | https://repositorio.udes.edu.co/handle/001/5665 | |
dc.language.iso | eng | spa |
dc.publisher.place | Suiza | spa |
dc.relation.citationissue | 2, febrero de 2020 | spa |
dc.relation.citationvolume | 9 | spa |
dc.relation.cites | Flórez-Castillo, J.M.; Rondón-Villareal, P.; Ropero-Vega, J.L.; Mendoza-Espinel, S.Y.; Moreno-Amézquita, J.A.; Méndez-Jaimes, K.D.; Farfán-García, A.E.; Gómez-Rangel, S.Y.; Gómez-Duarte, O.G. Ib-M6 Antimicrobial Peptide: Antibacterial Activity against Clinical Isolates of Escherichia coli and Molecular Docking. Antibiotics 2020, 9, 79. https://doi.org/10.3390/antibiotics9020079 | |
dc.relation.indexed | Antibiotics 2020, 9, 79; doi:10.3390/antibiotics9020079 | spa |
dc.relation.ispartofjournal | Antibiotics | spa |
dc.rights | The Editor(s) and the Author(s), 2020 | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.rights.creativecommons | Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) | spa |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | spa |
dc.source | https://www.mdpi.com/2079-6382/9/2/79#framed_div_cited_count | spa |
dc.subject.proposal | Antimicrobial peptides | eng |
dc.subject.proposal | Escherichia coli | eng |
dc.subject.proposal | Molecular docking | eng |
dc.title | Ib-M6 antimicrobial peptide: Antibacterial activity against clinical isolates of Escherichia coli and molecular docking | spa |
dc.type | Artículo de revista | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
dc.type.content | Text | spa |
dc.type.driver | info:eu-repo/semantics/article | spa |
dc.type.redcol | http://purl.org/redcol/resource_type/ART | spa |
dc.type.version | info:eu-repo/semantics/publishedVersion | spa |
dcterms.audience | Todas las Audiencias | spa |
dspace.entity.type | Publication | |
oaire.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
Archivos
Paquete original
1 - 1 de 1
- Nombre:
- Ib-M6 antimicrobial peptide. Antibacterial activity against clinical isolates of Escherichia coli and molecular docking.pdf
- Tamaño:
- 253.63 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
Paquete de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 59 B
- Formato:
- Item-specific license agreed upon to submission
- Descripción: